The knowledge-integrated network biomarkers discovery for major adverse cardiac events

Journal of Proteome Research

Volumn 7, Issue 9, 2008, Pages 4013-4021

  Jin, Guangxu ^a,b   Zhou, Xiaobo ^a   Wang, Honghui ^c   Zhao, Hong ^a   Cui, Kemi ^a   Zhang, Xiang Sun ^b   Chen, Luonan ^d   Hazen, Stanley L ^e   Li, King ^f   Wong, Stephen T C ^a  

^a Department of Obstetrics Gynecology   (United States)

^b CHINESE ACADEMY OF SCIENCES   (China)

^c HOUSTON METHODIST HOSPITAL   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e OSAKA SANGYO UNIVERSITY   (Japan)

^f CCF   (United States)

Author keywords

Cross validation; MACE; Mass spectrometry; Network biomarker; Proteomics; Systems biology

Indexed keywords

ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEOMICS; SIGNAL TRANSDUCTION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MASS SPECTROMETRY; METABOLISM; SYSTEMS BIOLOGY;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; HUMANS; MASS SPECTROMETRY; SYSTEMS BIOLOGY;

EID: 55249094833     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr8002886     Document Type: Article

References (37)

1. Malik, G.; Rojahn, E.; Ward, M. D.; Gretzer, M. B.; Partin, A. W.; Semmes, O. J.; Veltri, R. W. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression. Prostate 2007, 67 (14), 1565-75.
2. Oh, J. H.; Nandi, A.; Gurnani, P.; Knowles, L.; Schorge, J.; Rosenblatt, K. P.; Gao, J. X. Proteomic biomarker identification for diagnosis of early relapse in ovarian cancer. J. Bioinf. Comput. Biol. 2006, 4 (6), 1159-79.
3. Paweletz, C. P.; Liotta, L. A.; Petricoin, E. F. 3rd, New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics. Urology 2001, 57 (4 Suppl. 1), 160-3.
4. Vlahou, A.; Schellhammer, P. F.; Mendrinos, S.; Patel, K.; Kondylis, F. I.; Gong, L.; Nasim, S.; Wright, G. L., Jr. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am. J. Pathol. 2001, 158 (4), 1491-502.
5. Wulfkuhle, J. D.; McLean, K. C.; Paweletz, C. P.; Sgroi, D. C.; Trock, B. J.; Steeg, P. S.; Petricoin, E. F. New approaches to proteomic analysis of breast cancer. Proteomics 2001, 1 (10), 1205-15.
6. Cox, J.; Mann, M. Is proteomics the new genomics. Cell 2007, 130 (3), 395-8.
7. Hanash, S. M.; Pitted, S. J.; Faca, V. M. Mining the plasma proteome for cancer biomarkers. Nature 2008, 452 (7187), 571-9.
8. Rifai, N.; Gillette, M. A.; Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 2006, 24 (8), 971-83.
9. Simpson, R. J.; Bernhard, O. K.; Greening, D. W.; Moritz, R. L. Proteomics-driven cancer biomarker discovery: looking to the future. Curr. Opin. Chem. Biol. 2008, 12 (1), 72-7.
10. Slamon, D. J.; Leyland-Jones, B.; Shak, S.; Fuchs, H.; Paton, V.; Bajamonde, A.; Fleming, T.; Eiermann, W.; Wolter, J.; Pegram, M.; Baselga, J.; Norton, L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overex-presses HER2. N. Engl. J. Med. 2001, 344 (11), 783-92.
11. Asgeirsson, K. S.; Agrawal, A.; Allen, C; Hitch, A.; Ellis, I. O.;Chapman, C.; Cheung, K. L.; Robertson, J. F. Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients. Breast Cancer Res. 2007, 9 (6), R75.
12. Pal, S. K.; Pegram, M. HER2 targeted therapy in breast cancer⋯beyond Herceptin. Rev. Endocr. Metab. Disord. 2007, 8 (3), 269-77
13. Brennan, M. L.; Perm, M. S.; Van Lente, F.; Nambi, V.; Shishehbor, M. H.; Aviles, R. J.; Goormastic, M.; Pepoy, M. L.; McErlean, E. S.; Topol, E. J.; Nissen, S. E.; Hazen, S. L. Prognostic value of myeloperoxidase in patients with chest pain. N. Engl. J. Med. 2003, 349 (17), 1595-604.
14. McGuire, J. N.; Overgaard, J.; Pociot, F. Mass spectrometry is only one piece of the puzzle in clinical proteomics. Briefings Funct. Genomics Proteomics 2008, 7 (1), 74-83.
15. Barabasi, A. L.; Oltvai, Z. N. Network biology: understanding the cell's functional organization. Nat. Rev. Genet. 2004, 5 (2), 101-13.
16. Hartwell, L. H.; Hopfield, J. J.; Leibler, S.; Murray, A. W. From molecular to modular cell biology. Nature 1999, 402 (6761 Suppl.), C47-52.
17. Pawson, T.; Nash, P. Protein-protein interactions define specificity in signal transduction. Genes Dev. 2000, 14 (9), 1027-47.
18. Azpiazu, I.; Gautam, N. Role of G protein beta gamma complex in receptor-G protein interaction. Methods Enzymol. 2002, 344, 112-25.
19. Band, L.; Bertini, I.; Cantini, F.; Felli, I. C.; Gonneili, L.; Hadjiliadis, N.; Pierattelli, R.; Rosato, A.; Voulgaris, P. The Atxl-Ccc2 complex is a metal-mediated protein-protein interaction. Nat. Chem. Biol. 2006, 2 (7), 367-8.
20. Das, D.; Scovell, W. M. The binding interaction of HMG-1 with the TATA-binding protein/TATA complex. J. Biol. Chem. 2001, 276 (35), 32597-605.
21. Issaq, H. J.; Veenstra, T. D.; Conrads, T. P.; Felschow, D. The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem. Biophys. Res. Commun. 2002, 292 (3), 587-92.
22. Baggerly, K. A.; Morris, J. S.; Coombes, K. R. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics 2004, 20 (5), 777-85.
23. Karpievitch, Y. V.; Hill, E. G.; Smolka, A. J.; Morris, J. S.; Coombes, K. R.; Baggerly, K. A.; Almeida, I. S. PrepMS: TOF MS data graphical preprocessing tool. Bioinformatics 2007, 23 (2), 264-5.
24. Malyarenko, D. I.; Cooke, W. E.; Adam, B. L.; Malik, G.; Chen, H.; Tracy, E. R.; Trosset, M. W.; Sasinowski, M.; Semmes, O. J.; Manos, D. M. Enhancement of sensitivity and resolution of surface-enhanced laser desorption/ionization time-of-flight mass spec-trometric records for serum peptides using time-series analysis techniques. Clin. Chem. 2005, 51 (1), 65-74.
25. Bensmail, H.; Golek, J.; Moody, M. M.; Semmes, J. O.; Haoudi, A. A novel approach for clustering proteomics data using Bayesian fast Fourier transform. Bioinformatics 2005, 21 (10), 2210-24.
26. Perrin, C; Walczak, B.; Massart, D. L. The use of wavelets for signal denoising in capillary electrophoresis. Anal. Chem. 2001, 73 (20), 4903-17.
27. Wang, P.; Tang, H.; Zhang, H.; Whiteaker, J.; Paulovich, A. G.; Mcintosh, M. Normalization regarding non-random missing values in high-throughput mass spectrometry data. Pac. Symp. Biocom-put. 2006, 315-26.
28. Alfassi, Z. B. On the normalization of a mass spectrum for comparison of two spectra. J. Am. Soc. Mass Spectrom. 2004, 15 (3), 385-7.
29. Marcuson, R.; Burbeck, S. L.; Emond, R. L.; Latter, G. I.; Aberth, W. Normalization and reproducibility of mass profiles in the detection of individual differences from urine. Clin. Chem. 1982, 28 (6), 1346-8.
30. Bro, R.; Kjeldahl, K.; Smilde, A. K.; Kiers, H. A. Cross-validation of component models: a critical look at current methods. Anal. Bioanal. Chem. 2008, 390 (5), 1241-51.
31. Sundararajan, S.; Shevade, S.; Keerthi, S. S. Fast generalized cross-validation algorithm for sparse model learning. Neural Comput. 2007, 19 (1), 283-301.
32. Fu, W. J.; Carroll, R. J.; Wang, S. Estimating misclassification error with small samples via bootstrap cross-validation. Bioinformatics 2005, 21 (9), 1979-86.
33. Mavroforakis, M. E.; Theodoridis, S. A geometric approach to support vector machine (SVM) classification. IEEE Trans. Neural Networks 2006, 17 (3), 671-82.
34. Byvatov, E.; Schneider, G. SVM-based feature selection for characterization of focused compound collections. J. Chem. Inf. Comput. Sci. 2004, 44 (3), 993-9.
35. Allantaz, F.; Chaussabel, D.; Banchereau, J.; Pascual, V. Microarray-based identification of novel biomarkers in IL-1-mediated diseases. Curr. Opin. Immunol. 2007, 19 (6), 623-32.
36. Chuang, H. Y.; Lee, E.; Liu, Y. T.; Lee, D.; Ideker, T. Network-based classification of breast cancer metastasis. Mol. Syst. Biol. 2007, 3, 140.
37. Koopmann, J.; Zhang, Z.; White, N.; Rosenzweig, J.; Fedarko, N.; Jagannath, S.; Canto, M. I.; Yeo, C. J.; Chan, D. W.; Goggins, M. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin. Cancer Res. 2004, 10 (3), 860-8.